Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):125-135. doi: 10.1097/QAI.0000000000001660.
J Acquir Immune Defic Syndr. 2018.
PMID: 29474268
Free PMC article.
Review.
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
Boffito M, Waters L, Cahn P, Paredes R, Koteff J, Van Wyk J, Vincent T, Demarest J, Adkison K, Quercia R.
Boffito M, et al. Among authors: koteff j.
AIDS Res Hum Retroviruses. 2020 Jan;36(1):13-18. doi: 10.1089/AID.2019.0171. Epub 2019 Oct 21.
AIDS Res Hum Retroviruses. 2020.
PMID: 31507204
Free PMC article.
Review.
Item in Clipboard
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis.
Eron J, Hung CC, Baril JG, Slim J, Falcó V, Bogner J, Maggiolo F, Mills A, Sievers J, Man CY, Urbaityte R, Underwood M, Tenorio AR, Pappa KA, Wynne B, Koteff J, Gartland M, Smith KY, Aboud M.
Eron J, et al. Among authors: koteff j.
J Acquir Immune Defic Syndr. 2020 May 1;84(1):60-65. doi: 10.1097/QAI.0000000000002302.
J Acquir Immune Defic Syndr. 2020.
PMID: 31977595
Clinical Trial.
Item in Clipboard
Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study.
Trottier B, Lake JE, Logue K, Brinson C, Santiago L, Brennan C, Koteff JA, Wynne B, Hopking J, Granier C, Aboud M.
Trottier B, et al. Among authors: koteff ja.
Antivir Ther. 2017;22(4):295-305. doi: 10.3851/IMP3166. Epub 2017 Apr 12.
Antivir Ther. 2017.
PMID: 28401876
Clinical Trial.
Item in Clipboard
HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.
Patel R, Evitt L, Mariolis I, Di Giambenedetto S, d'Arminio Monforte A, Casado J, Cabello Úbeda A, Hocqueloux L, Allavena C, Barber T, Jha D, Kumar R, Kamath RD, Vincent T, van Wyk J, Koteff J.
Patel R, et al. Among authors: koteff j.
Infect Dis Ther. 2021 Dec;10(4):2051-2070. doi: 10.1007/s40121-021-00522-7. Epub 2021 Aug 24.
Infect Dis Ther. 2021.
PMID: 34426899
Free PMC article.
Review.
Item in Clipboard
A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.
Koteff J, Borland J, Chen S, Song I, Peppercorn A, Koshiba T, Cannon C, Muster H, Piscitelli SC.
Koteff J, et al.
Br J Clin Pharmacol. 2013 Apr;75(4):990-6. doi: 10.1111/j.1365-2125.2012.04440.x.
Br J Clin Pharmacol. 2013.
PMID: 22905856
Free PMC article.
Clinical Trial.
Item in Clipboard
Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study.
Trottier B, Lake JE, Logue K, Brinson C, Santiago L, Brennan C, Koteff JA, Wynne B, Hopking J, Granier C, Aboud M.
Trottier B, et al. Among authors: koteff ja.
Antivir Ther. 2017;22(5):459-460. doi: 10.3851/IMP3192. Epub 2017 Sep 13.
Antivir Ther. 2017.
PMID: 28901945
No abstract available.
Item in Clipboard
Cite
Cite